Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000166118 | SCV000216888 | likely benign | Hereditary cancer-predisposing syndrome | 2018-06-05 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV001082367 | SCV000641612 | benign | Tuberous sclerosis 1 | 2024-01-24 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000733529 | SCV000861606 | uncertain significance | not provided | 2018-06-11 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000733529 | SCV001915253 | benign | not provided | 2021-02-05 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001082367 | SCV002040019 | benign | Tuberous sclerosis 1 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV001082367 | SCV005404677 | likely benign | Tuberous sclerosis 1 | 2024-08-14 | criteria provided, single submitter | clinical testing | This variant is considered likely benign. This variant has been observed at a population frequency that is significantly greater than expected given the associated disease prevalence and penetrance. |